- Largest Veterinary Emergency Hospital in Tel Aviv Acquires Sensus Healthcare’s SRT-100™ to Provide Gentler Radiotherapy to Treat Tumors in Dogs and Cats
- Sensus Healthcare Announces Sale of First SRT-100 Vision™ System to Asia
- Sensus Healthcare Issues Reminder That its First Quarter 2024 Financial Results and Business Update Conference Call Will be Held on Thursday, May 9, 2024
- Sensus Healthcare to Host First Quarter 2024 Financial Results and Business Update Conference Call on Thursday, May 9, 2024
- Sensus Healthcare to Participate in the 36th Annual Roth Conference
- Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting
- Sensus Healthcare Issued U.S. Patent for SRT-100 Vision® System (IG-SRT) Capabilities
- Sensus Healthcare Collaborates with CureRays to Provide Oversight to Help Customers Assure Patient Safety, Reliability of Outcomes and Conformance with Regulatory Requirements
- Sensus Healthcare Announces Retirement of Director Samuel O’Rear
- Sensus Healthcare to Host Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call on Thursday, February 8, 2024
More ▼
Key statistics
As of last trade Sensus Healthcare Inc (SRTS:NAQ) traded at 6.14, -6.26% below its 52-week high of 6.55, set on May 17, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.96 |
---|---|
High | 6.30 |
Low | 5.83 |
Bid | 6.14 |
Offer | 6.17 |
Previous close | 5.92 |
Average volume | 649.38k |
---|---|
Shares outstanding | 16.39m |
Free float | 13.25m |
P/E (TTM) | 20.77 |
Market cap | 97.04m USD |
EPS (TTM) | 0.2851 USD |
Data delayed at least 15 minutes, as of May 24 2024 18:21 BST.
More ▼